GENERIC NAME OF THE MEDICINAL PRODUCT
A. Etophylline and Theophylline Prolonged Release Tablets IP (231MG+69MG)
B. Etophylline and Theophylline Prolonged Release Tablets IP (115MG+50MG)
C. Etophylline and Theophylline Prolonged Release Tablets IP (77MG+23MG)
B. Etophylline and Theophylline Prolonged Release Tablets IP (115MG+50MG)
C. Etophylline and Theophylline Prolonged Release Tablets IP (77MG+23MG)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….231mg
Theophylline IP Anhydrous
Eq. to Theophylline IP Hydrate………………69mg
Excipients………………………….................……q.s
Colour: Quinoline Yellow WSS
B) Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….115mg
Theophylline IP Anhydrous
Eq. to Theophylline IP Hydrate………………50mg
Excipients………………………….................……q.s
Colour: Titanium Dioxide IP
C) Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….77mg
Theophylline IP Anhydrous
Eq. to Theophylline IP Hydrate………………23mg
Excipients………………………….................……q.s
Colour: Sunset Yellow FCF
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….231mg
Theophylline IP Anhydrous
Eq. to Theophylline IP Hydrate………………69mg
Excipients………………………….................……q.s
Colour: Quinoline Yellow WSS
B) Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….115mg
Theophylline IP Anhydrous
Eq. to Theophylline IP Hydrate………………50mg
Excipients………………………….................……q.s
Colour: Titanium Dioxide IP
C) Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….77mg
Theophylline IP Anhydrous
Eq. to Theophylline IP Hydrate………………23mg
Excipients………………………….................……q.s
Colour: Sunset Yellow FCF
THERAPEUTIC INDICATIONS:
This medication is used in the treatment and prevention of chronic obstructive pulmonary disease. they work by relaxing the muscles in the airways and widen the airways. this makes breathing easier.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablets to be swallowed as a whole, and not to be chewed or crushed.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablets to be swallowed as a whole, and not to be chewed or crushed.
STORAGE & DOSAGE:
Storage: Store at a temperature not exceeding 25℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the physician.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the physician.
Etophylline and Theophylline Prolonged Release Tablets IP (77MG+23MG) Technical specification:
| Product Name: | Etophylline and Theophylline Prolonged Release Tablets IP |
| Brand Name: | Generic |
| Strength: | 231mg+69mg, 115mg+50mg, 77mg+23mg |
| Dosage Form: | Tablets (film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 Strips of 10 Tablets Each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Bronchodilators |
| Indication: | This medication is used in the treatment and prevention of chronic obstructive pulmonary disease. they work by relaxing the muscles in the airways and widen the airways. this makes breathing easier. |
| Storage: | Store at a temperature not exceeding 25℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Etophylline and Theophylline Prolonged Release Tablets IP (231MG+69MG)
- Etophylline and Theophylline Prolonged Release Tablets IP (115MG+50MG)
- Etophylline and Theophylline Prolonged Release Tablets IP (77MG+23MG)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….231mg
Theophylline IP Anhydrous
to Theophylline IP Hydrate………………69mg
Excipients………………………………………..……q.s
Colour: Quinoline Yellow WSS - Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….115mg
Theophylline IP Anhydrous
to Theophylline IP Hydrate………………50mg
Excipients………………………………………..……q.s
Colour: Titanium Dioxide IP - Etophylline and Theophylline Prolonged Release Tablets IP
Each film-coated prolonged release tablet contains:
Etophylline…………………………………………….77mg
Theophylline IP Anhydrous
to Theophylline IP Hydrate………………23mg
Excipients………………………………………..……q.s
Colour: Sunset Yellow FCF
THERAPEUTIC INDICATIONS:
- This medication is used in the treatment and prevention of chronic obstructive pulmonary disease. they work by relaxing the muscles in the airways and widen the airways. this makes breathing easier.
CAUTION & WARNING:
- CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.Tablets to be swallowed as a whole, and not to be chewed or crushed.
STORAGE & DOSAGE:
- Storage: Store at a temperature not exceeding 25℃. Store in cool, dry & dark place. Protect from Light & moisture.
- Dosage: As directed by the physician.
